Appointed as a Non-Executive in January 2021. Olivier is also a member of the Remuneration and CRSEC Committees.
Olivier was CEO of FTSE 100 medical devices company Smith & Nephew plc from 2011 to 2018. Prior to that, he served as CEO of healthcare, cosmetology and pharmaceutical company Laboratoires Pierre Fabre from 2010 to 2011, and from 2003 to 2010 he worked at Abbott Laboratories, rising to Corporate Executive Vice President and President of the pharmaceutical products division. Earlier in his career, Olivier worked at GlaxoSmithKline plc in positions of increasing seniority. He also served on the Board of Smiths Group plc from July 2018 to November 2020. Olivier became a Knight of the Legion of Honour in 2007. Olivier has a doctorate in Pharmacy from the University of Paris-Sud and an MBA from HEC business school in Paris.
Skills and experience
Olivier is a successful leader, with many years’ experience as CEO of a large, global company. Olivier has a wealth of experience in healthcare products and markets and brings great insight to the Board.
Current external appointments
Chair of Majorelle
External Director of Takeda Pharmaceutical Company Limited
Member of the Supervisory Board of Virbac SA
Co-Founder and Board member of AlgoTherapeutix SAS
Member of the National Pharmacy Academy
Member of the Academy of Technologies